Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Tests MINIject implant with cataract surgery for glaucoma and cataract

Tests a MINIject eye implant with cataract surgery in adults with glaucoma.

Key facts

Who runs it
iSTAR Medical
Where
Panama City, PanamaSee the siteAlso in 2 other countries, 3 sites
Trial code
Registry title
MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract
Status
Enrolling by invitation
People taking part
30 people, planned
Started
18 Jan 2023
Planned end
Jul 2025
Type of study
Interventional
Treatments tested
  • Phacoemulsification combined with minimally invasive glaucoma surgery (MIGS)
Record updated
28 February 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with primary open-angle glaucoma that eye drops do not control well, who also have a cataract that can be operated on. The MINIject implant is placed during cataract surgery.

Age
40 years or older
Sex
Men and women
Disease stage
Primary open-angle glaucoma in the study eye, plus an age-related cataract that can be removed with phacoemulsification surgery and an intraocular lens implant.
Earlier treatment
Glaucoma not well controlled with at least one eye-pressure-lowering eye drop, unless the person is allergic to or cannot tolerate the medication.

Main reasons for not taking part

  • Known or suspected allergy to medical silicone
  • Allergy to fluorescein
  • Silicone oil in the study eye
  • Under tutorship or trusteeship
  • Unable to give personal informed consent

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Diagnosis of primary open angle glaucoma (POAG) in the study eye
  • Operable age-related cataract eligible for phacoemulsification surgery with Intraocular Lens (IOL) implantation
  • Glaucoma not adequately controlled with at least one topical hypotensive medication(s), unless the patient has an allergy / intolerance to a medication
  • Patient must provide written informed consent to participate

Who cannot take part

  • Known or suspected allergy or hypersensitivity to medical silicone
  • Allergy to fluorescein
  • Patient has a condition such that his / her ability to provide personal informed consent is compromised
  • Presence of silicone oil in the study eye
  • Individuals under tutorship or trusteeship

Where in Panama

Also in 2 other countries, 3 sites

  • Panama Eye CenterPanama City, PanamaNo longer taking part

About the trial

What the trial wants to find out

The study will assess safety and performance of MINIject implant in patients with open-angle glaucoma uncontrolled by topical hypotensive medications in conjunction with cataract surgery.

The group in the trial

  • Treatment groupTreatment being tested

    Treatment: Phacoemulsification combined with minimally invasive glaucoma surgery (MIGS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Prospective, Open, Multicenter Clinical Trial Evaluating the Efficacy and Safety of MINIject Combined With Cataract Surgery in Patients With POAG Uncontrolled by Topical Hypotensive Medications and Operable Age-related Cataract Diagnosis
Plain-language title
Tests MINIject implant with cataract surgery for glaucoma and cataractGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
28 February 2025